Duque-Afonso J, Finke J, Ferhat-Berland T, Galimard JE, et al. Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of Bone Marrow Transplant 2026 Sep 10. doi: 10.1038/s41409-026-03016.
PMID: 42722785